BACKGROUND: Particulate air pollution has been associated with several adverse cardiovascular health outcomes, and people with diabetes may be especially vulnerable. One potential pathway is inflammation and endothelial dysfunction-processes in which cell adhesion molecules and inflammatory markers play important roles. AIM: To examine whether plasma levels of soluble intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and von Willebrand factor (vWF) were associated with particle exposure in 92 Boston area residents with type 2 diabetes. METHODS: Daily average ambient levels of air pollution (fine particles (PM2.5), black carbon (BC) and sulphates) were measured approximately 500 m from the patient examination site and evaluated for associations with ICAM-1, VCAM-1 and vWF. Linear regressions were fit to plasma levels of ICAM-1, VCAM-1 and vWF, with the particulate pollutant index, apparent temperature, season, age, race, sex, glycosylated haemoglobin, cholesterol, smoking history and body mass index as predictors. RESULTS: Air pollutant exposure measures showed consistently positive point estimates of association with the inflammatory markers. Among participants not taking statins and those with a history of smoking, associations between PM(2.5), BC and VCAM-1 were particularly strong. CONCLUSIONS: These results corroborate evidence suggesting that inflammatory mechanisms may explain the increased risk of air pollution-associated cardiovascular events among those with diabetes.
BACKGROUND: Particulate air pollution has been associated with several adverse cardiovascular health outcomes, and people with diabetes may be especially vulnerable. One potential pathway is inflammation and endothelial dysfunction-processes in which cell adhesion molecules and inflammatory markers play important roles. AIM: To examine whether plasma levels of soluble intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and von Willebrand factor (vWF) were associated with particle exposure in 92 Boston area residents with type 2 diabetes. METHODS: Daily average ambient levels of air pollution (fine particles (PM2.5), black carbon (BC) and sulphates) were measured approximately 500 m from the patient examination site and evaluated for associations with ICAM-1, VCAM-1 and vWF. Linear regressions were fit to plasma levels of ICAM-1, VCAM-1 and vWF, with the particulate pollutant index, apparent temperature, season, age, race, sex, glycosylated haemoglobin, cholesterol, smoking history and body mass index as predictors. RESULTS: Air pollutant exposure measures showed consistently positive point estimates of association with the inflammatory markers. Among participants not taking statins and those with a history of smoking, associations between PM(2.5), BC and VCAM-1 were particularly strong. CONCLUSIONS: These results corroborate evidence suggesting that inflammatory mechanisms may explain the increased risk of air pollution-associated cardiovascular events among those with diabetes.
Authors: A Nemmar; P H M Hoet; B Vanquickenborne; D Dinsdale; M Thomeer; M F Hoylaerts; H Vanbilloen; L Mortelmans; B Nemery Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Moti Haim; David Tanne; Valentina Boyko; Tamar Reshef; Uri Goldbourt; Jonathan Leor; Yoseph A Mekori; Solomon Behar Journal: J Am Coll Cardiol Date: 2002-04-03 Impact factor: 24.094
Authors: I Malik; J Danesh; P Whincup; V Bhatia; O Papacosta; M Walker; L Lennon; A Thomson; D Haskard Journal: Lancet Date: 2001-09-22 Impact factor: 79.321
Authors: Sonia A Gurgueira; Joy Lawrence; Brent Coull; G G Krishna Murthy; Beatriz González-Flecha Journal: Environ Health Perspect Date: 2002-08 Impact factor: 9.031
Authors: Yuh-Chin T Huang; Michael Schmitt; Zhonghui Yang; Loretta G Que; Judith C Stewart; Mark W Frampton; Robert B Devlin Journal: Inhal Toxicol Date: 2010-08 Impact factor: 2.724
Authors: Jennifer L Nichols; Elizabeth Oesterling Owens; Steven J Dutton; Thomas J Luben Journal: Int J Public Health Date: 2013-07-28 Impact factor: 3.380
Authors: S Kriemler; S Manser-Wenger; L Zahner; C Braun-Fahrländer; C Schindler; J J Puder Journal: Diabetologia Date: 2008-06-17 Impact factor: 10.122
Authors: S Kannan; J T Dvonch; A J Schulz; B A Israel; G Mentz; J House; P Max; A G Reyes Journal: J Epidemiol Community Health Date: 2010-01 Impact factor: 3.710